2021 annual financial data
Skye Bioscience 2021 Operating cash flow margin
Skye Bioscience 2021 operating cash flow margin with verified reported values.
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -7,847,714 USD and net income was -8,522,182 USD.
Operating cash flow was -6,474,888 USD.
Get free Skye Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -7,847,714 USD
- Net income
- -8,522,182 USD
- Operating cash flow
- -6,474,888 USD